⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Figure S2 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer

Nicole A. Traphagen Gary N. Schwartz Steven Tau Alyssa M. Roberts Amanda Jiang Sarah R. Hosford Jonathan D. Marotti Abigail E. Goen Bianca A. Romo Anneka L. Johnson Emily-Claire K. Duffy Eugene Demidenko Paul Heverly Yaron Mosesson Shannon M. Soucy Fred Kolling Todd W. Miller

View at Publisher

Ask AI

Bookmark

Share

Abstract

Supplementary Figure S2- E2 induces DNA damage in LTED and ER-overexpressing cells.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Traphagen et al. (2024) studied this question.

synapsesocial.com/papers/68e58589b6db643587522797 https://doi.org/10.1158/1078-0432.27033094.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S2 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer2024
2Supplementary Figure S3 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer2024
3Supplementary Figure S4 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer2024
4Supplementary Figure S4 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer2024
5Supplementary Figure S11 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer2024

Supplementary Figure S11 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer2024
Supplementary Figure S1 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer2024
Supplementary Figure S1 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer2024